TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28905172

Group type: EXPERIMENTAL
Intervention: Extended-duration betrixaban (80 mg once daily for 35-42 days)
Number of subjects: 3261

Group type: COMPARATOR
Intervention: Standard-of-care enoxaparin (40 mg once daily for 10±4 days)
Number of subjects: 3261
Study: 25752889

Group type: EXPERIMENTAL
Intervention: THC 0.75 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: THC 1.5 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: THC pharmacokinetics
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 23312704

Group type: EXPERIMENTAL
Intervention: Hp2‐2 genotype with elevated HbA(1c) (≥ 6.5%)
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Hp2‐2 genotype with HbA(1c) <6.5%
Number of subjects: 407
Study: 21333015

Group type: EXPERIMENTAL
Intervention: School-based psychological intervention (cognitive-behavioural models); 11 weekly sessions and 3 booster sessions.
Number of subjects: 2600

Group type: COMPARATOR
Intervention: Usual but enhanced counselling sessions in control schools.
Number of subjects: 2600
Study: 19875762

Group type: EXPERIMENTAL
Intervention: Counseling intervention (10 in-person at home and 4 telephone sessions over 6 months)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Counseling intervention
Number of subjects: 150
Study: 18044100

Group type: EXPERIMENTAL
Intervention: Creatine supplementation
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 15156769

Group type: EXPERIMENTAL
Intervention: Low frequency noise (LFN) at 50 dB(A)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Broadband noise at comparable levels of 50 dB(A)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Background laboratory noise of about 30 dB(A)
Number of subjects: 193
Study: 11505744

Group type: EXPERIMENTAL
Intervention: Amlodipine (2.5-10 mg once daily)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Enalapril (5-20 mg once daily)
Number of subjects: 176
Study: 9385238

Group type: EXPERIMENTAL
Intervention: Operative treatment (proximal realignment procedures)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Closed treatment
Number of subjects: 125
Study: 7957511

Group type: COMPARATOR
Intervention: 10 mg isosorbide dinitrate (ISDN)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 2.5 mg pirsidomine
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 10 mg pirsidomine
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 2890307

Group type: EXPERIMENTAL
Intervention: Targeted medication plus psychosocial intervention
Number of subjects: 42

Group type: COMPARATOR
Intervention: Continuous medication
Number of subjects: 42
Study: 29661990

Group type: EXPERIMENTAL
Intervention: Traffic noise
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Forest birdsong
Number of subjects: 83

Group type: COMPARATOR
Intervention: Control condition (no auditory stimuli)
Number of subjects: 83
Study: 28466749

Group type: EXPERIMENTAL
Intervention: Empowerment intervention (6 weeks of information booklets and face-to-face discussions)
Number of subjects: 112
Study: 26490492

Group type: EXPERIMENTAL
Intervention: Total dietary resveratrol plus total urinary resveratrol (TDR + TUR)
Number of subjects: 769

Group type: COMPARATOR
Intervention: Not applicable (control group not specified)
Number of subjects: 769
Study: 23964932

Group type: EXPERIMENTAL
Intervention: Vedolizumab (300 mg) intravenously at weeks 0 and 2
Number of subjects: 895

Group type: EXPERIMENTAL
Intervention: Vedolizumab every 8 weeks
Number of subjects: 895

Group type: EXPERIMENTAL
Intervention: Vedolizumab every 4 weeks
Number of subjects: 895

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 895
Study: 20615906

Group type: EXPERIMENTAL
Intervention: Citrate-enriched dialysate (3 mEq/L)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional saline flushing
Number of subjects: 24
Study: 18447215

Group type: EXPERIMENTAL
Intervention: Point sticking therapy (Sanleng, Ezhu, Zhi Nanxing, Bingpian applied to Qihai, Guanyuan, and Ashi points)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Oral administration of Rupixiao (control group)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Point sticking therapy
Number of subjects: 63
Study: 16324916

Group type: EXPERIMENTAL
Intervention: Pioglitazone (PIO) 45 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ephedrine (25 mg TID) plus caffeine (200 mg TID)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination therapy (Pioglitazone + Ephedrine + Caffeine)
Number of subjects: 0
Study: 14615440

Group type: EXPERIMENTAL
Intervention: Auricular acupuncture at points with electrodermal signal
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo auricular acupuncture at points with no electrodermal signal
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo auricular seeds fixed at placebo points
Number of subjects: 90
Study: 11037586

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laparoscopic hernia repair
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laparoscopic fundoplication
Number of subjects: 0
Study: 9366532

Group type: EXPERIMENTAL
Intervention: Torso phased‐array (TPA) coil with four acquisitions
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Torso phased‐array (TPA) coil with two acquisitions
Number of subjects: 60

Group type: COMPARATOR
Intervention: Body coil with four acquisitions
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Body coil and TPA coil
Number of subjects: 60
Study: 1389731

Group type: EXPERIMENTAL
Intervention: Streptokinase (1.5 x 10(6) IU)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Anistreplase (30U)
Number of subjects: 128
Study: 4017422

Group type: EXPERIMENTAL
Intervention: Intravenous felodipine (2.5 mg infusion over 30 minutes)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Oral felodipine (27.5 mg solution)
Number of subjects: 8
Study: 30963811

Group type: EXPERIMENTAL
Intervention: Independent self-affirmation
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Interdependent self-affirmation
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Interaction between self-affirmation type and self-construal
Number of subjects: 186
Study: 29852045

Group type: EXPERIMENTAL
Intervention: Adenopharyngoplasty (APP)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Adenotonsillectomy (ATE)
Number of subjects: 83
Study: 26605955

Group type: EXPERIMENTAL
Intervention: Recruitment strategies by community health workers
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Retention strategies by community health workers
Number of subjects: 23
Study: 25384797

Group type: EXPERIMENTAL
Intervention: Animated graphic symbols with environmental sounds
Number of subjects: 46

Group type: COMPARATOR
Intervention: Animated graphic symbols without environmental sounds
Number of subjects: 46
Study: 22570363

Group type: EXPERIMENTAL
Intervention: JNJ-18038683
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 225

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 225

Group type: COMPARATOR
Intervention: Post hoc analysis
Number of subjects: 225
Study: 20184565

Group type: EXPERIMENTAL
Intervention: Catholic religious affiliation
Number of subjects: 2773

Group type: EXPERIMENTAL
Intervention: Cuban-American ethnicity
Number of subjects: 2773

Group type: EXPERIMENTAL
Intervention: U.S.-born status
Number of subjects: 2773

Group type: EXPERIMENTAL
Intervention: Male gender
Number of subjects: 2773

Group type: EXPERIMENTAL
Intervention: Higher acculturation
Number of subjects: 2773

Group type: EXPERIMENTAL
Intervention: More education
Number of subjects: 2773

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 2773

Group type: EXPERIMENTAL
Intervention: Never married status
Number of subjects: 2773

Group type: EXPERIMENTAL
Intervention: Higher income
Number of subjects: 2773

Group type: EXPERIMENTAL
Intervention: Unemployment
Number of subjects: 2773
Study: 17268946

Group type: EXPERIMENTAL
Intervention: Fetal Movement Chart (FMC) proposed by CLAP
Number of subjects: 1400

Group type: COMPARATOR
Intervention: Count-to-10 method
Number of subjects: 1400
Study: 16215339

Group type: EXPERIMENTAL
Intervention: Rofecoxib 50 mg preoperatively
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo preoperatively
Number of subjects: 45
Study: 12473552

Group type: EXPERIMENTAL
Intervention: Intravenous platelet GP IIb/IIIa inhibitors
Number of subjects: 627

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 627
Study: 9932951

Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gabapentin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lamotrigine
Number of subjects: 0
Study: 7607719

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (54 mmol/d)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 2136871

Group type: EXPERIMENTAL
Intervention: Alprazolam (4-9 mg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Amitriptyline (100-225 mg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 30
Study: 69290

Group type: EXPERIMENTAL
Intervention: Diamorphine (diacetylmorphine, heroin)
Number of subjects: 699

Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Diamorphine
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Anxiolytic medication
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Diamorphine and Morphine
Number of subjects: 699
Study: 31356426

Group type: EXPERIMENTAL
Intervention: SystemCHANGE (SC) intervention
Number of subjects: 30

Group type: COMPARATOR
Intervention: Attention Control (AC) intervention
Number of subjects: 30
Study: 29658257

Group type: EXPERIMENTAL
Intervention: Ningmitai Capsules (NMT)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Doxycycline hydrochloride (DH)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Ningmitai Capsules + Doxycycline hydrochloride (NMT+DH)
Number of subjects: 240
Study: 25908066

Group type: EXPERIMENTAL
Intervention: 6-week clopidogrel therapy
Number of subjects: 614

Group type: COMPARATOR
Intervention: 6-month clopidogrel therapy
Number of subjects: 614
Study: 23636549

Group type: EXPERIMENTAL
Intervention: Physical activity intervention
Number of subjects: 996
Study: 21288215

Group type: EXPERIMENTAL
Intervention: Propofol at ETsevo 3%
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Propofol at ETsevo 3.5%
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Propofol at ETsevo 4%
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Propofol 1.5-2 mg/kg
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 63
Study: 19635155

Group type: EXPERIMENTAL
Intervention: Preoperative IABP therapy
Number of subjects: 221

Group type: COMPARATOR
Intervention: Postoperative IABP therapy
Number of subjects: 221
Study: 17306698

Group type: EXPERIMENTAL
Intervention: Pulsed ultrasound (US)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Continuous ultrasound (US)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control
Number of subjects: 10
Study: 14742358

Group type: EXPERIMENTAL
Intervention: Arctic Sun Temperature Management System (AS group)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Conventional methods (control group)
Number of subjects: 29
Study: 12890209

Group type: EXPERIMENTAL
Intervention: Itraconazole pulse therapy for 2 months and amorolfine 5% solution nail lacquer for 6 months
Number of subjects: 90

Group type: COMPARATOR
Intervention: Itraconazole monotherapy (three pulses)
Number of subjects: 90
Study: 10225576

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 500 mg
Number of subjects: 518

Group type: EXPERIMENTAL
Intervention: Cefotaxime 1 g
Number of subjects: 518

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 518
Study: 8730501

Group type: EXPERIMENTAL
Intervention: 2 MU/m2/t.i.w. for 6 months
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 2 MU/m2/t.i.w. for 12 months
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 4 MU/m2/t.i.w. for 6 months
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 4 MU/m2/t.i.w. for 12 months
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: HCV genotype III or V
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: HCV genotype I or II
Number of subjects: 160
Study: 2228842

Group type: EXPERIMENTAL
Intervention: One day course of injectable cefotaxime
Number of subjects: 116

Group type: COMPARATOR
Intervention: Five day oral course of co-amoxyclav (amoxycillin plus clavulanic acid)
Number of subjects: 116
Study: 637271

Group type: EXPERIMENTAL
Intervention: Labetalol with 1% halothane and spontaneous respiration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Labetalol with 1% halothane and controlled respiration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Labetalol with 3% halothane and spontaneous respiration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Halothane alone (without labetalol)
Number of subjects: 0
Study: 31992234

Group type: EXPERIMENTAL
Intervention: Intensive psychotherapy and case management (IPCM)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Care-as-usual (CAU)
Number of subjects: 214
Study: 31267367

Group type: COMPARATOR
Intervention: JNJ-6379 (25 to 600 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: 150 mg JNJ-6379 twice daily for 2 days, followed by 100 mg JNJ-6379 daily for 10 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: JNJ-6379
Number of subjects: 30
Study: 28377156

Group type: EXPERIMENTAL
Intervention: Milk protein supplementation (2 × 15 g, twice daily) during 24 weeks of resistance-type exercise training
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo during 24 weeks of resistance-type exercise training
Number of subjects: 34
Study: 26412802

Group type: EXPERIMENTAL
Intervention: Taspoglutide injected subcutaneously in the abdomen
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Taspoglutide injected subcutaneously in the upper arm
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Taspoglutide injected subcutaneously in the thigh
Number of subjects: 60

Group type: COMPARATOR
Intervention: Period 2 versus Period 1
Number of subjects: 60

Group type: COMPARATOR
Intervention: Period 3 versus Period 1
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Taspoglutide injected in the abdomen
Number of subjects: 60
Study: 23567307

Group type: EXPERIMENTAL
Intervention: Probiotic strains (Bifidobacterium lactis BB‐12 1 x 10^9 CFU and Streptococcus thermophilus TH‐4 1 x 10^8 CFU)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no probiotics)
Number of subjects: 60
Study: 20073999

Group type: EXPERIMENTAL
Intervention: Sulfasalazine
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Pentoxifylline
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Sulfasalazine and Pentoxifylline
Number of subjects: 32

Group type: COMPARATOR
Intervention: Methotrexate
Number of subjects: 32
Study: 18851885

Group type: EXPERIMENTAL
Intervention: One of nine treatments for depression
Number of subjects: 243
Study: 17522118

Group type: EXPERIMENTAL
Intervention: 150 W bicycle exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 70% maximal power output (W(max)) bicycle exercise
Number of subjects: 0
Study: 15198760

Group type: EXPERIMENTAL
Intervention: Povidone-iodine gel (20 cc) at the vaginal apex
Number of subjects: 1570

Group type: COMPARATOR
Intervention: Control group (no povidone-iodine gel)
Number of subjects: 1570
Study: 11489711

Group type: EXPERIMENTAL
Intervention: Electrodiagnostic testing using pudendal somatosensory evoked potentials and bulbocavernosus reflex latency measurements in 14 patients with CPPS.
Number of subjects: 45

Group type: COMPARATOR
Intervention: Thermal sensory analysis testing on the perineum and anterior thigh using noxious heat stimuli in 31 patients with CPPS and 14 controls.
Number of subjects: 45
Study: 9507413

Group type: EXPERIMENTAL
Intervention: Cerebral artery stenosis
Number of subjects: 47

Group type: COMPARATOR
Intervention: No cerebral artery stenosis
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Age and presence of arterial stenosis
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Focal cerebral signs
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Glasgow Outcome Scale (GOS)
Number of subjects: 47
Study: 7995011

Group type: COMPARATOR
Intervention: Nitroglycerin (intravenous infusion during the first 24 hours, then 10 mg/day transdermal)
Number of subjects: 1526

Group type: COMPARATOR
Intervention: Lisinopril (5 then 10 mg/day)
Number of subjects: 1526

Group type: COMPARATOR
Intervention: Control (neither intervention)
Number of subjects: 1526

Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 1526
Study: 30588836

Group type: EXPERIMENTAL
Intervention: Hydroxytyrosol and Vitamin E
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 28104096

Group type: EXPERIMENTAL
Intervention: U‐Healthcare intervention (Internet‐based integrated management)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Conventional medical treatment (control group)
Number of subjects: 212
Study: 26031346

Group type: EXPERIMENTAL
Intervention: Anxiety and Negative Urgency
Number of subjects: 193
Study: 23828228

Group type: EXPERIMENTAL
Intervention: Simvastatin (n=30) for 16 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Decapeptyl (n=30) every 4 weeks for 4 doses
Number of subjects: 60
Study: 22212269

Group type: EXPERIMENTAL
Intervention: Exercise group (EG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 30
Study: 19558539

Group type: EXPERIMENTAL
Intervention: Topiramate 100 mg/day
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 331
Study: 16397162

Group type: EXPERIMENTAL
Intervention: TAAG intervention designed to be appropriate for both sexes, addressing girls' stated preferences and barriers for physical activity.
Number of subjects: 0
Study: 15456517

Group type: EXPERIMENTAL
Intervention: Multispecies probiotic preparation (Ecologic 641) administered twice daily through a nasojejunal tube for 28 days or until discharge.
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo administered twice daily through a nasojejunal tube for 28 days or until discharge.
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Multispecies probiotic preparation (Ecologic 641)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 10786739

Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia with 8 mg of 0.5% hyperbaric bupivacaine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Combined sciatic‐femoral nerve block with 25 ml of mepivacaine 20 mg ml(‐1)
Number of subjects: 50
Study: 9310807

Group type: EXPERIMENTAL
Intervention: Urapidil
Number of subjects: 81

Group type: COMPARATOR
Intervention: Sodium nitroprusside
Number of subjects: 81
Study: 8362808

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3527523

Group type: EXPERIMENTAL
Intervention: Human ultralente insulin
Number of subjects: 6

Group type: COMPARATOR
Intervention: Porcine lente insulin
Number of subjects: 6
Study: 29940921

Group type: EXPERIMENTAL
Intervention: Adapted cognitive‐behavioral stress management (CBSM) course delivered via WeChat for 3 months, including motivation for physical activities.
Number of subjects: 300

Group type: COMPARATOR
Intervention: Brochure on nutrition for PLWH plus standard care (control group).
Number of subjects: 300
Study: 27428746

Group type: EXPERIMENTAL
Intervention: Children infected with HIV in utero (IU)
Number of subjects: 13647

Group type: EXPERIMENTAL
Intervention: Children infected with HIV intrapartum (IP)
Number of subjects: 13647

Group type: EXPERIMENTAL
Intervention: Children infected with HIV postnatally (PN)
Number of subjects: 13647

Group type: EXPERIMENTAL
Intervention: HIV-exposed uninfected (HEU) children
Number of subjects: 13647

Group type: COMPARATOR
Intervention: HIV-unexposed children
Number of subjects: 13647
Study: 24302269

Group type: EXPERIMENTAL
Intervention: Atrial fibrillation (AF) patients with left atrial enlargement and reduced LAEF
Number of subjects: 971

Group type: EXPERIMENTAL
Intervention: Increasing electrical burden of AF and higher CHADS2 scores
Number of subjects: 971

Group type: EXPERIMENTAL
Intervention: AF subjects with normal LA size
Number of subjects: 971

Group type: EXPERIMENTAL
Intervention: AF subjects in sinus rhythm at echocardiography
Number of subjects: 971
Study: 22856338

Group type: EXPERIMENTAL
Intervention: 5.0 cm wide elastic cuff
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 13.5 cm wide non-elastic cuff
Number of subjects: 27

Group type: COMPARATOR
Intervention: BFR exercise (both cuffs)
Number of subjects: 27
Study: 19887763

Group type: EXPERIMENTAL
Intervention: Physical exercise and diet intervention
Number of subjects: 1410
Study: 18605455

Group type: EXPERIMENTAL
Intervention: Fu Fang Ya Tong Ding
Number of subjects: 120

Group type: COMPARATOR
Intervention: iodine glycerol
Number of subjects: 120

Group type: COMPARATOR
Intervention: routine rinsing treatment (negative group)
Number of subjects: 120
Study: 15794740

Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of valsartan and captopril
Number of subjects: 0
Study: 12492913

Group type: EXPERIMENTAL
Intervention: Randomized Controlled Trials in periodontal research (RCT-Ps)
Number of subjects: 675

Group type: EXPERIMENTAL
Intervention: Clinical Trials in periodontal research (CT-Ps)
Number of subjects: 675

Group type: EXPERIMENTAL
Intervention: RCT-Ps covering periodontal surgery and gingivitis/plaque treatment or prevention
Number of subjects: 675

Group type: EXPERIMENTAL
Intervention: RCT-Ps published in two different journals
Number of subjects: 675

Group type: EXPERIMENTAL
Intervention: RCT-Ps from the U.S.A
Number of subjects: 675
Study: 10406339

Group type: EXPERIMENTAL
Intervention: Carbon dioxide (CO2) insufflation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Air insufflation
Number of subjects: 100
Study: 7584752

Group type: EXPERIMENTAL
Intervention: Padded long spine board
Number of subjects: 30

Group type: COMPARATOR
Intervention: Unpadded long spine board
Number of subjects: 30